SDL-001

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameSDL-001
Drug Alias NameSDL-001SDL001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD38Anti-BCMAAnti-GPRC5D
TargetsLymphocyte differentiation antigen CD38B-cell maturation proteinG-protein coupled receptor family C group 5member D
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynthetic Design Lab Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynthetic Design Lab Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A